Author Interview: Professor Kevin Winthrop (December 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA

Prof Iain McInnes reviews two papers this month, and discusses exposure-adjusted incidence rates of TEAEs and AESIs with filgotinib, as well as the efficacy and safety of tofacitinib in pJIA.

Author Interview: Professor Kevin Winthrop (November 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA

Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis.

Author Interview: Professor Atul Deodhar

Professor Atul Deodhar, professor of medicine at Oregon Health & Science University.

Author Interview: Professor Roy Fleischmann

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.